Baker Brothers Advisors - BELLICUM PHARMACEUTICALS INC ownership

BELLICUM PHARMACEUTICALS INC's ticker is and the CUSIP is 079481404. A total of 30 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of BELLICUM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$82,211
-54.2%
249,1230.0%0.00%
-100.0%
Q4 2022$179,369
-40.0%
249,1230.0%0.00%
-50.0%
Q3 2022$299,000
+1.0%
249,1230.0%0.00%0.0%
Q2 2022$296,000
-45.0%
249,1230.0%0.00%
-33.3%
Q1 2022$538,000
+45.0%
249,1230.0%0.00%
+50.0%
Q4 2021$371,000
-49.0%
249,1230.0%0.00%
-33.3%
Q3 2021$727,000
-11.6%
249,1230.0%0.00%
-25.0%
Q2 2021$822,000
-12.3%
249,1230.0%0.00%0.0%
Q1 2021$937,000
+6.6%
249,1230.0%0.00%
+33.3%
Q4 2020$879,000
-46.3%
249,1230.0%0.00%
-57.1%
Q3 2020$1,637,000
-11.6%
249,1230.0%0.01%
-12.5%
Q2 2020$1,851,000
+57.8%
249,1230.0%0.01%
+14.3%
Q1 2020$1,173,000249,1230.01%
Other shareholders
BELLICUM PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Ikarian Capital, LLC 500,000$1,881,0000.06%
AJU IB Investment Co., Ltd. 25,651$96,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 53,041$199,0000.01%
Baker Brothers Advisors 249,123$937,0000.00%
SHUFRO ROSE & CO LLC 12,941$49,0000.00%
Squarepoint Ops LLC 27,915$105,0000.00%
Tekla Capital Management LLC 6,000$23,0000.00%
Orion Capital Management LLC 500$2,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 13,300$50,0000.00%
BANK OF AMERICA CORP /DE/ 26$00.00%
View complete list of BELLICUM PHARMACEUTICALS INC shareholders